Reuters logo
4 months ago
BRIEF-PledPharma gets advice from FDA for continued development of PledOx
May 2, 2017 / 6:15 AM / 4 months ago

BRIEF-PledPharma gets advice from FDA for continued development of PledOx

May 2 (Reuters) - PLEDPHARMA AB (PUBL)

* PLEDPHARMA RECEIVES ADVICE FROM THE FDA FOR THE CONTINUED DEVELOPMENT OF PLEDOX® Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below